Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Danièle
Danièle Barion, Les Roches De Condrieu FR
| Patent application number | Description | Published |
|---|---|---|
| 20110257318 | CLEAR SYNTHETIC BINDER - The disclosure relates to a clear synthetic binder comprising at least one oil of plant origin, at least one resin of petroleum origin and at least one polymer, the amount of oil of plant origin in the binder is greater than or equal to 10% by weight and the amount of polymer in the binder is less than or equal to 15% by weight. The clear synthetic binder according to the disclosure has a good consistency, a reduced viscosity, and suitable behaviour at low temperature and elastic properties. The disclosure also relates to a bituminous mix prepared from said clear synthetic binder, this bituminous mix is prepared at temperatures between 100° C. and 160° C., preferably between 120° C. and 140° C. and has suitable rutting resistance and water resistance. | 10-20-2011 |
Danièle Bonnet-Delpon, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20080287433 | DERIVATIVES OF ARTEMISININ, AND THEIR USES IN THE TREATMENT OF MALARIA - A new artemisinin derivatives, of following general formula (I): | 11-20-2008 |
| 20100266570 | DIMERIC DERIVATIVES OF ARTEMISININ AND APPLICATION IN ANTICANCER THERAPY - The present invention relates to dimeric derivatives of 10-trifluoromethylated artemisinin of formula (I): or a pharmaceutically acceptable salt thereof with B | 10-21-2010 |
| 20110152289 | DIMERIC DERIVATIVES OF ARTEMISININ AND APPLICATION IN ANTI-CANCER THERAPY - The present invention relates to dimeric derivatives of 10-trifluoromethylated artemisinin of formula (I) below: Formula (I) and the pharmaceutically acceptable salts thereof, and also to the preparation method thereof and to the uses thereof, especially in the treatment of cancer. | 06-23-2011 |
Danièle Bonnet-Delpon, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100266570 | DIMERIC DERIVATIVES OF ARTEMISININ AND APPLICATION IN ANTICANCER THERAPY - The present invention relates to dimeric derivatives of 10-trifluoromethylated artemisinin of formula (I): or a pharmaceutically acceptable salt thereof with B | 10-21-2010 |
Danièle Gilbert, Saint-Pierre De Varengeville FR
| Patent application number | Description | Published |
|---|---|---|
| 20090305434 | METHOD OF DIAGNOSING NEUROPHSYCHIATRIC DISEASES, EATING DISORDERS OR METABOLIC DISEASES - The application relates to a method of diagnosing neuropsychiatric diseases, eating disorders and/or metabolic diseases, which comprises: (i) measuring the affinity and/or the avidity of antibodies, derived from a biological sample, directed against a biological molecule involved in homeostatic regulation and/or in motivational behavior and/or in emotion; (ii) comparing the affinity value obtained with a control value. | 12-10-2009 |
Danièle Maubon, Saint Ismier FR
| Patent application number | Description | Published |
|---|---|---|
| 20120034593 | CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY - The present invention relates to a method for preparing a cyclic peptide with antiparasite activity and anticancer activity. The invention also relates to this peptide as an antiparasite agent, for example in the treatment of toxoplasmosis and as an anticancer agent. The invention also relates to the use of this cyclic peptide for treating organs ex vivo before transplantation. | 02-09-2012 |
Danièle Tenza, Survilliers FR
| Patent application number | Description | Published |
|---|---|---|
| 20110038853 | Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis - The present invention relates to novel pharmaceutical or cosmetic compositions comprising at least one inhibitor of a sub-unit of AP-1 adaptor complex, of a kinesin interacting with AP-1, in particular Kif13A, or of the interaction between a sub-unit of AP-1 adaptor complex and said kinesin, as well as the use of same to manufacture a drug intended for the treatment of pigmentary disorders and as a depigmentation agent. | 02-17-2011 |
Danièle Tenza, Survilliers FR
| Patent application number | Description | Published |
|---|---|---|
| 20110038853 | Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis - The present invention relates to novel pharmaceutical or cosmetic compositions comprising at least one inhibitor of a sub-unit of AP-1 adaptor complex, of a kinesin interacting with AP-1, in particular Kif13A, or of the interaction between a sub-unit of AP-1 adaptor complex and said kinesin, as well as the use of same to manufacture a drug intended for the treatment of pigmentary disorders and as a depigmentation agent. | 02-17-2011 |